Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

NEOPAX FILM-COATED TABLET 400MG - HSA Drug Approval Details

Approvals/HSA/NEOPAX FILM-COATED TABLET 400MG

Approved

THERAPEUTIC

NEOPAX FILM-COATED TABLET 400MG

Krka-Farma d.o.o.🇸🇬 Health Sciences Authority

Approval Date: Aug 16, 2024
Approval ID: 0ae71d2f3647d713
Company: Krka-Farma d.o.o.
Type: Therapeutic

Approval Details

Approval Id: 0ae71d2f3647d713
Drug Name: NEOPAX FILM-COATED TABLET 400MG
Product Name: NEOPAX FILM-COATED TABLET 400MG
Approval Number: SIN17065P
Approval Date: 2024-08-16
Registrant: SINGAPORE PHARMACEUTICAL PRIVATE LIMITED
Drug Type: Therapeutic
Forensic Classification: Prescription Only
Dosage Form: TABLET, FILM COATED
Route Of Administration: ORAL
Atc Code: L01EA01
Pharma Manufacturer Name: SINGAPORE PHARMACEUTICAL PRIVATE LIMITED
Company Detail Path: /organization/a2ca8c6cb2ae4ff1/singapore-pharmaceutical-private-limited

Active Ingredients

Imatinib mesylate eqv Imatinib

400mg

Imatinib mesylate eqv Imatinib

400mg

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Aug 16, 2024

Approval ID

0ae71d2f3647d713

Type

Therapeutic

Back to HSA Approvals